Provider review
Pallas Health Review: "$199 a Month" Is Billed Every 12 Weeks
Pallas Health advertises compounded semaglutide at "$199/month" and compounded tirzepatide at "$299/month". Neither is a monthly price. Both are a 12-week charge — $597 and $897 — divided by three, and 12 weeks is not three months. A 12-week cycle comes round 4.33 times a year, so the semaglutide year is $2,587 rather than the $2,388 the advertised figure implies, and the tirzepatide year is $3,887 rather than $3,588. That is one extra charge each, arriving in a year the reader thought held twelve payments. Almost everything else here is unusually straight: Pallas names all six of the pharmacies that fill its prescriptions, names its clinical partner and its advising physician, holds LegitScript certification, has no FDA warning letter of its own, and lets you cancel free at any time.
Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.
$567/mo
All fifty states plus the District of Columbia…
Every 12 weeks (4.33×/yr)
August 2026
All fifty states plus the District of Columbia, with 52 `/glp-1/<state>` paths published. Pallas states that care is fully asynchronous in 43 states, and it names the exceptions rather than leaving them vague: Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota and West Virginia, plus Washington, D.C., all require a real-time video visit before a prescription is issued. In those, checkout collects a $60 visit deposit instead of the first payment and credits it against the first order.
At a glance
$567/mo
Advertised
$567/mo
Walk-away
$2,457
True year
The same NAD+ — nasal spray price, three ways
The short bar is the number Pallas Health leads with. It lasts one cycle.
Advertised
first cycle only
$567
Walk-away
every cycle after
$567
Ready to check Pallas Health’s current price?
Verified August 2026. Prices may change.
What’s included
- The compounded medication, shipped free, when it is prescribed
- The clinician review and ongoing check-ins, at one plan price rather than a separate consult fee
- Care-team messaging and a self-serve portal at pallashealth.co/portal
- A full refund if a clinician decides treatment is not right for you
- Klarna pay-over-time at checkout, if you would rather spread the first charge
Pricing, per compound
Pallas Health prices each compound separately, so there is no single “Pallas Health” price — only a price per compound. The table below shows, for each one, the price it leads with in the “Advertised” column and what a reader actually pays if they stop after one cycle in “Walk-away”, cheapest first. The “Provider” column names the compound, not the company — every row on this page is Pallas Health.
| Provider | Advertised | Walk-away | True year |
|---|---|---|---|
NAD+ — nasal spray Advertised as "$189/month", billed as $567 every 12 weeks, making the year $2,457 rather than the $2,268 implied. First month $79. This is the cheapest thing Pallas sells that a reader can actually buy. Verified · source | $567.00/mo | $567.00/mo | $2,457.00 $567.00 × 4.333333333333333 months |
NAD+ — subcutaneous injection Advertised as "$199/month", billed as $597 every 12 weeks — the same 12-week cycle as the GLP-1s, so the year is $2,587 rather than $2,388. First month $89. The nasal-spray form is cheaper at $567 every 12 weeks ("$189/month", $79 first month). Read at `/get-started/nad/productSelect`, which offers those two forms and no others. Verified · source | $597.00/mo | $597.00/mo | $2,587.00 $597.00 × 4.333333333333333 months |
Semaglutide — compounded Pallas advertises this as "$199/month". The charge is $597 every 12 weeks, and $597 ÷ 3 is $199 — so the per-cycle number is honest and the headline gap is zero. The unit is not: Pallas's own chunk stamps the renewal `renewalWeeks: 12` and then averages it with `Math.round(renewalCents/300)`, dividing 12 weeks by three months. A 12-week cycle arrives 52/12 = 4.33 times a year, so the year is $2,587 and not the $2,388 that "$199/mo" implies. The first four weeks are $139 as an intro rate, not the standing one, and renewals are anchored to 12 weeks starting four weeks after clinician approval. There is no month-to-month rung for the compounded GLP-1s at all. Verified · source | $597.00/mo | $597.00/mo | $2,587.00 $597.00 × 4.333333333333333 months |
Tirzepatide — compounded Advertised as "$299/month", billed as $897 every 12 weeks. Same arithmetic as the semaglutide row and the same conclusion: $897 ÷ 3 = $299 is right per cycle, but 4.33 cycles a year makes the year $3,887 rather than $3,588. The first four weeks are $179 as an intro rate. Read at the `medicationSelect` step of Pallas's own funnel, where both molecules are shown side by side with separate prices — the selector does not default you onto one. Verified · source | $897.00/mo | $897.00/mo | $3,887.00 $897.00 × 4.333333333333333 months |
True year assumes 13 payments a year for compounds billed every 4 weeks, and 12 for compounds billed monthly — see the arithmetic under each row.
Pros and cons
Pros
- It names all six pharmacies.
- It names the clinical side too: Lion MD as the treating group…
- The per-cycle price is exactly what the marketing implies.
- Cancelling is free and self-serve, effective at the end of the current billing period.
- No FDA warning letter for Pallas…
- LegitScript Healthcare Merchant certification, verified as issued rather than taken from the footer badge.
Cons
- "$199/month" is not a monthly price, and the gap is one whole extra charge a year.
- There is no month-to-month option for the compounded GLP-1s at any price.
- The $139 and $179 opening rates are intro pricing for the first four weeks…
- Pallas's own code carries a monthly/quarterly/6-month/12-month ladder for both molecules that the funnel…
- A third NAD+ product…
- In the seven states requiring a video visit…
How we verified this
What we checked
- Semaglutide — compounded priced against pallashealth.co, August 2026
- Tirzepatide — compounded priced against pallashealth.co, August 2026
- NAD+ — subcutaneous injection priced against pallashealth.co, August 2026
- NAD+ — nasal spray priced against pallashealth.co, August 2026
- States, inclusions, and terms checked August 2026
What to double-check before you buy
- Pallas advertises this as "$199/month".
- Advertised as "$299/month", billed as $897 every 12 weeks.
- Advertised as "$199/month"…
- Advertised as "$189/month", billed as $567 every 12 weeks, making the year $2,457 rather than the $2,268 implied.
- Prices may change. Always confirm against the source link before you buy.
Key terms
Show definitions
- Walk-away price
- What one cycle costs at the no-commitment, ongoing rate — what you actually pay if you stop after month one.
- True year
- The walk-away price multiplied by however many times a year it's actually billed — 12 for a calendar-month cycle, 13 for a four-week cycle.
- Four-weekly billing
- A cycle that repeats every 4 weeks rather than on the calendar month, so it bills 13 times in a year, not 12 — one extra charge a reader counting by "months" won't expect.
- Compounded
- Made to order by a pharmacy from raw ingredients, rather than dispensed as an FDA-approved, mass-manufactured product.
Bottom line
Pallas Health’s cheapest walk-away price is $567/mo (NAD+ — nasal spray) — about $2,457 a year if you keep paying it every cycle. Check the pricing table above for every compound this provider sells before you commit to one.
Visit Pallas HealthFrequently asked questions
What does Pallas Health actually cost per year?
$2,587 for compounded semaglutide and $3,887 for compounded tirzepatide, after the first four weeks. Those figures come from Pallas's own billing cadence: $597 and $897 charged every 12 weeks, and a 12-week cycle comes round 52/12 = 4.33 times in a year. The advertised "$199/month" and "$299/month" imply $2,388 and $3,588 — each about one charge short, because each treats 12 weeks as if it were three months.
Is the "$199 a month" figure dishonest?
Not about the money, and yes about the calendar. $597 divided by three genuinely is $199, and one 12-week block genuinely does contain about three months of medicine — so unlike much of this roster, Pallas is not hiding a fee or quoting a prepay rate it will not honour. What it does is divide a 12-week charge by three months and print the result with a "/mo" on it. Twelve weeks is 84 days; three months is about 91. The seven-day difference is small until you multiply it across a year, at which point it is an entire extra payment.
Can I pay Pallas monthly instead?
Not for the compounded GLP-1s or for NAD+. The funnel offers a first month at an intro rate, and after that the only rung is the 12-week block. Pallas's code does contain a monthly ladder for both molecules, and a $99 month-to-month NAD+ tablet, but the live funnel does not offer any of them and there is no page on the site that sells them.
Which pharmacy fills the prescription?
One of six that Pallas names publicly on its /clinical page: Belmar, Strive, The Pharmacy Hub, Foothills and two others, chosen by the medication, the patient's state and availability. Pallas states plainly that it does not own or operate a pharmacy. Naming them at all puts Pallas ahead of most of this roster — and it means the one piece of history worth knowing is checkable: Belmar received an FDA warning letter in March 2023 about compounding quality, and the FDA closed that letter out in October 2023.
What happens if a clinician says no?
You are refunded in full. That applies both to the plan price and to the $60 video-visit deposit charged in the seven states that require a synchronous visit. The exception Pallas states is abandonment: if you neither attend nor reschedule a required video visit and drop out of the intake, the deposit may be kept.
Sources
Every price above was checked against Pallas Health’s own pricing page — never a third-party aggregator:
Show every source link
- Pallas Health — official site
First-party source for every fact on this page
- Semaglutide — compounded pricing
Verified August 2026
- Tirzepatide — compounded pricing
Verified August 2026
- NAD+ — subcutaneous injection pricing
Verified August 2026
- NAD+ — nasal spray pricing
Verified August 2026
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.